Breaking News

DS Healthcare Signs Long-Term Supply Pact

By Kristin Brooks | February 10, 2014

To provide formulation, ingredients and technology for a topical product

DS Healthcare Group has signed an agreement with a global healthcare company to provide the formulation, ingredients and its technology for use in a topical product. The product when launched will be distributed by the global healthcare company under their own brand following successful development. DS Healthcare will act as the exclusive ingredient supplier for five years, which will automatically renew under certain conditions.
 
"This agreement with a leader in the global healthcare market is a clear indication of the strength of our innovation. DS Healthcare has built a reputation of excellence for our products that has led to this agreement. This is an exciting project that we believe will reach new milestones for us," said DS Healthcare president and chief executive officer Daniel Khesin.
blog comments powered by Disqus
  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • The Role of Alliances in Modern Drug Development

    The Role of Alliances in Modern Drug Development

    Dr. Claire Madden-Smith, Senior Vice President, Juniper Pharma Services||September 8, 2016
    Combining expertise to get drug candidates through development

  • Limiting APIs in Manufacturing Effluent

    Limiting APIs in Manufacturing Effluent

    Joan Tell, Robert Drinane, Bruce Naumann, Jessica Vestel, and Gregory Gagliano, Merck & Co., Inc.||June 2, 2016
    An approach for setting limits on pharmaceuticals discharged in manufacturing effluent